Synergetics USA: Shift in Corporate Strategy Yields Strong First Quarter Results
Synergetics USA reported first quarter revenues of $12.2 million, an increase of 17% over the year ago period. More compelling was the increase in net […]
feature2
AngioDynamics Seeks CEO, Issues Downside Guidance
Changes are afoot at Queensbury NY-based AngionDynamics. The company said yesterday that it would begin the search for a new CEO to replace company co-founder […]
[Video Profile] EyeMarker Systems
EyeMarker Systems is developing an ocular imaging device that can determine if a person has been exposed to certain toxic agents (botulinum, nerve agents, cyanide) […]
Biolase Cuts Jobs Citing a Weak Capital Equipment Marketplace
Dental laser maker Biolase Technology has slashed 20 percent of its domestic workforce. The company will save $2 million a quarter as a result. Additional […]
Terminated: Minrad International Ends Agreement with RxElite
Minrad International has terminated its distribution agreement with RxElite. The action was taken after the RxElite failed to pay $5.6 million in accounts owed to […]
[Video Profile] Interview with Michael Fons, VP Corporate Development at Inovio Biomedical
Inovio Biomedical’s electroporation technology uses brief, controlled electrical pulses to increase cellular uptake of gene expression in DNA-based treatments; this enhances the potency of DNA-based […]
Liquidity Crisis: Minrad International Slashes Jobs, Evaluates Options
In an effort to improve its cost structure and conserve cash, Minrad International said it would layoff 35 percent of its workforce, or some 50 […]
Endologix Rejects Elliott Associates Buyout Bid
Regular Sentinel readers know I’m a fan of Endologix. The developer of a minimally invasive treatment for abdominal aortic aneurysms has had a slate of […]
Cyberkinetics Neurotechnology Nearing Paralysis
In a recent filing, Cyberkinetics Neurotechnology said it only had enough cash to last 30 days. If negotiations fail with its secured creditor, GE Capital, […]
AngioDynamics Integrates Diomed’s EVLT
Having acquired onetime rival Diomed for a song, AngioDynamics has launched a new varicose vein therapy brand, VenaCure EVLT. The new brand combines AngioDynamics’ VenaCure […]